A new AI-powered, tear-based biomarker test can now detect keratoconus, a progressive eye disease, even before symptoms appear. This non-invasive method offers early diagnosis and better treatment outcomes. Clinical validation is underway, along with the development of a rapid diagnostic kit for surface eye diseases.